UBS analyst Jon Windham lowered the firm’s price target on WM (WM) to $225 from $240 and keeps a Neutral rating on the shares. The price target has been adjusted to reflect concerns on WM Healthcare Solutions’ customer retention, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WM: